We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LVOXU
426
DELISTED
LiveVox Holding, Inc. Unit
LVOXU
| $6.03M | 0.05% |
600,000
| – | – |
|
427
New York Times
NYT
$12.2B
| $6.02M | 0.05% |
+184,629
| New | +$6.15M |
|
428
Union Pacific
UNP
$175B
| $5.98M | 0.05% |
35,381
-1,369
| -4% | -$235K |
|
429
Sonic Automotive
SAH
$3.31B
| $5.91M | 0.05% |
253,175
+155,281
| +159% | +$2.99M |
|
430
Perdoceo Education
PRDO
$2.06B
| $5.83M | 0.05% |
+305,473
| New | +$5.63M |
|
|
GTHX
431
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $5.81M | 0.05% |
189,486
+104,562
| +123% | +$2.2M |
|
|
HSII
432
DELISTED
Heidrick & Struggles
HSII
| $5.78M | 0.05% |
192,970
-84,401
| -30% | -$2.96M |
|
|
BIG
433
DELISTED
Big Lots, Inc.
BIG
| $5.73M | 0.05% |
200,208
+95,019
| +90% | +$3.17M |
|
|
SRDX
434
DELISTED
Surmodics
SRDX
| $5.71M | 0.05% |
132,150
+79,908
| +153% | +$3.37M |
|
435
Progress Software
PRGS
$1.66B
| $5.69M | 0.05% |
130,450
-310,768
| -70% | -$13.5M |
|
|
TMX
436
DELISTED
Terminix Global Holdings, Inc.
TMX
| $5.68M | 0.05% |
+109,097
| New | +$5.61M |
|
|
TBRG
437
DELISTED
TruBridge
TBRG
| $5.63M | 0.05% |
202,408
-842
| -0.4% | -$23.5K |
|
438
Transocean
RIG
$5.52B
| $5.62M | 0.05% |
876,548
+322,921
| +58% | +$2.4M |
|
|
CSFL
439
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $5.6M | 0.05% |
243,270
-426,632
| -64% | -$10M |
|
|
LMNX
440
DELISTED
Luminex Corp
LMNX
| $5.57M | 0.05% |
270,026
+74,346
| +38% | +$1.63M |
|
441
Ameris Bancorp
ABCB
$5.9B
| $5.55M | 0.05% |
141,709
-228,414
| -62% | -$8.34M |
|
442
Costco
COST
$429B
| $5.54M | 0.05% |
20,948
+3,021
| +17% | +$753K |
|
|
XRN
443
Chiron Real Estate Inc
XRN
$541M
| $5.54M | 0.05% |
105,443
-28,329
| -21% | -$1.48M |
|
444
Neogen
NEOG
$2B
| $5.52M | 0.05% |
177,624
-182,310
| -51% | -$5.37M |
|
445
Entegris
ENTG
$18B
| $5.51M | 0.05% |
147,534
-128,224
| -46% | -$4.86M |
|
446
AtriCure
ATRC
$2.01B
| $5.5M | 0.05% |
184,241
+167,333
| +990% | +$4.89M |
|
447
Autodesk
ADSK
$50.1B
| $5.48M | 0.05% |
33,625
+24,846
| +283% | +$4.18M |
|
448
Houlihan Lokey
HLI
$10.2B
| $5.43M | 0.04% |
122,056
+121,310
| +16,261% | +$5.67M |
|
449
Accuray
ARAY
$29M
| $5.41M | 0.04% |
1,397,648
-254,691
| -15% | -$1.03M |
|
450
Universal Insurance Holdings
UVE
$1.23B
| $5.39M | 0.04% |
+193,056
| New | +$5.65M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.